Envoy Medical Inc. (COCH)vsEdwards Lifesciences Corp (EW)
COCH
Envoy Medical Inc.
$6.63
+2.00%
HEALTHCARE · Cap: $48.98M
EW
Edwards Lifesciences Corp
$94.44
+2.90%
HEALTHCARE · Cap: $52.90B
Smart Verdict
WallStSmart Research — data-driven comparison
Edwards Lifesciences Corp generates 3145939% more annual revenue ($6.51B vs $207,000). EW leads profitability with a 15.4% profit margin vs 0.0%. EW earns a higher WallStSmart Score of 53/100 (C-).
COCH
Avoid15
out of 100
Grade: F
EW
Buy53
out of 100
Grade: C-
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
+56.6%
Fair Value
$1.52
Current Price
$6.63
$5.11 discount
Margin of Safety
+68.5%
Fair Value
$251.45
Current Price
$94.44
$157.01 discount
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Conservative balance sheet, low leverage
Conservative balance sheet, low leverage
Safe zone — low bankruptcy risk
Large-cap with strong market position
Strong operational efficiency at 29.8%
Areas to Watch
0.0% earnings growth
Smaller company, higher risk/reward
ROE of 0.0% — below average capital efficiency
0.0% margin — thin
Expensive relative to growth rate
Weak financial health signals
Premium valuation, high expectations priced in
Earnings declined 25.4%
Comparative Analysis Report
WallStSmart ResearchBull Case : COCH
The strongest argument for COCH centers on Debt/Equity.
Bull Case : EW
The strongest argument for EW centers on Debt/Equity, Altman Z-Score, Market Cap. Profitability is solid with margins at 15.4% and operating margin at 29.8%. Revenue growth of 13.6% demonstrates continued momentum.
Bear Case : COCH
The primary concerns for COCH are EPS Growth, Market Cap, Return on Equity.
Bear Case : EW
The primary concerns for EW are PEG Ratio, Piotroski F-Score, P/E Ratio. A P/E of 54.6x leaves little room for execution misses.
Key Dynamics to Monitor
COCH profiles as a value stock while EW is a mature play — different risk/reward profiles.
COCH carries more volatility with a beta of 1.95 — expect wider price swings.
EW is growing revenue faster at 13.6% — sustainability is the question.
EW generates stronger free cash flow (585M), providing more financial flexibility.
Bottom Line
EW scores higher overall (53/100 vs 15/100), backed by strong 15.4% margins and 13.6% revenue growth. COCH offers better value entry with a 56.6% margin of safety. Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Envoy Medical Inc.
HEALTHCARE · MEDICAL DEVICES · USA
Envoy Medical Corporation manufactures and markets an implantable hearing aid device. The company is headquartered in White Bear Lake, Minnesota.
Edwards Lifesciences Corp
HEALTHCARE · MEDICAL DEVICES · USA
Edwards Lifesciences is an American medical technology company headquartered in Irvine, California, specializing in artificial heart valves and hemodynamic monitoring.
Visit Website →Compare with Other MEDICAL DEVICES Stocks
Want to dig deeper into these stocks?